chrisvoncsefalvay/vaers-outcomes huggingface dataset:
recieved the Moderna covid booster yesterday and is week; recieved the Moderna covid booster yesterday and throwing up; This spontaneous case was reported by a pharmacist and describes the occurrence of ASTHENIA (recieved the Moderna covid booster yesterday and is week) and VOMITING (recieved the Moderna covid booster yesterday and throwing up) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced ASTHENIA (recieved the Moderna covid booster yesterday and is week) and VOMITING (recieved the Moderna covid booster yesterday and throwing up). At the time of the report, ASTHENIA (recieved the Moderna covid booster yesterday and is week) and VOMITING (recieved the Moderna covid booster yesterday and throwing up) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product was provided by the reporter. No treatment medication was provided.   Reporter did not allow further contact
Sudden inability to move and delirious and hallucinating.  Hospital ran numerous tests to find problem without being able to determine.
WHEN CHILD WAS PUT INTO CAR SEAT AFTER INJECTIONS, SHE BEGAN FEELING HOT AND ITCHING, WAS TAKEN TO EMERGENCY ROOM WHERE MOM WORKS, CHILD PASSED OUT, LETHARGIC, VOMITING, IN AND OUT OF CONSCIOUSNESS, ADMITTED TO PEDIATRIC INTENSIVE CARE.
Patient presented with chief complaint of shortness of breath after having 2 weeks of symptoms of fever, chills, cough, sore throat and diarrhea with poor appetite and loss of taste and smell.  Patient was found to be hypoxic at 84% on room air, tachycardic with which he was admitted for further evaluation and management.  He was initiated on dexamethasone, Rocephin and azithromycin.  The patient had an extended complicated hospital course of 65 days during which multiple subspecialists have evaluated him and managed his comorbidities including respiratory failure secondary to COVID-19 pneumonia. Patient received tocilizumab on November 24th.  Patient was on high-dose steroids which were gradually tapered down. Patient's respiratory status at this time improved but he continues to be oxygen dependent at 3-4 L with severe day saturations on exertion to low 80s needing 8-10 L oxygen support with a Ventimask and recovery time of less than 5 min to bring his saturations above 90%.  Patient was discharged with a 10 L oxygen concentrator along with home oxygen.  Patient was also treated with Mycamine for  Covid fungal infection because of prolonged steroid usage.
Aches, chills, pain within first 24 hours, then developed a rash over my whole body beginning in left arm and progressing over the following 7 days to the remainder of my body. Appeared similar to a poison ivy rash, red and inflamed, extremely itchy, burning sensation. It progressed to an infection at the first two rash sites on the left side of the body. As of 10 days from vaccine, still experiencing severe itchy skin that is not relieved by antihistamines. Currently am taking prednisone and doxycycline, antihistamines to control itching. New areas of rash are still occurring.
Rash - vesicular, erythematous clusters scattered over arm, thorax, abdomen, leg.
No additional adverse event, and no further information provided; Nurse called to report a dose of VAQTA that was inadvertently administered after its labeled expiry date. Involved VAQTA expired on 11-JAN-2021 and was administered on 18-JAN-2021; This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant therapies were not reported.   On 18-JAN-2021, the patient was inadvertent vaccinated with  an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) 1 dose of 0.5 milliliter (route of administration, anatomical location and vaccine scheme were not provided), lot number S032359 has been verified to be a valid lot number, expiration date was on 11-JAN-2021, as prophylaxis (expired product administered).There was no prior temperature excursions reported. The nurse inquired about need for revaccination. No additional adverse event, and no further information provided. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S032359; expirationdate: 11-JAN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
CHILD RECEIVED INCORRECT FORMULATION FOR AGE GROUP. CHILD NOT 5YO AT TIME OF VACCINATION AND RECEIVED FORMULATION FOR AGES 5-11YO. PARENT ENTERED INCORRECT DOB IN CONSENT FORM WHICH WOULD'VE MADE THE CHILD 5.
The patient was contacted to determine if she got the vaccine 7 days early or not as the patient appeared in the scheduling tool for 4/2/21, but our system showed that she got her second vaccine on 3/26/21. She stated that she "freaked out" and wanted to get it early so she came before her scheduled appointment. The patient inadvertently got the vaccination on 3/26/21.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2013, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot number not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. In 2014, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
"Big spot circle" around 4 inches in diameter with blisters on it on the injection site; Itching; "big spot circle" around 4 inches in diameter with blisters on it on the injection site; Soreness on the area of the injection; Not feeling very good; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Not feeling very good), VACCINATION SITE VESICLES ("Big spot circle" around 4 inches in diameter with blisters on it on the injection site), PRURITUS (Itching), VACCINATION SITE BRUISING ("big spot circle" around 4 inches in diameter with blisters on it on the injection site) and VACCINATION SITE PAIN (Soreness on the area of the injection) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION COMPLICATION (Not feeling very good) and VACCINATION SITE PAIN (Soreness on the area of the injection). On 25-Feb-2021, the patient experienced VACCINATION SITE VESICLES ("Big spot circle" around 4 inches in diameter with blisters on it on the injection site), PRURITUS (Itching) and VACCINATION SITE BRUISING ("big spot circle" around 4 inches in diameter with blisters on it on the injection site). On 17-Feb-2021, VACCINATION COMPLICATION (Not feeling very good) and VACCINATION SITE PAIN (Soreness on the area of the injection) had resolved. On 27-Feb-2021, PRURITUS (Itching) had resolved. At the time of the report, VACCINATION SITE VESICLES ("Big spot circle" around 4 inches in diameter with blisters on it on the injection site) and VACCINATION SITE BRUISING ("big spot circle" around 4 inches in diameter with blisters on it on the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were provided. Treatment done by Cortisone cream.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant FU received on 20 JUL 2021: Events Outcome was updated.
About 24 hours after receiving the vaccine she had sudden onset of moderate to severe depression. Prior to the vaccine she had been in remission and felt better than she had in years. The depression is persistent as of 3 weeks after vaccine.
Severe allergic reaction, anaphylaxis, throat itching, tachycardia, trembling, stomach pain. Treated immediately  with epinephrine and Benadryl.   Several hours later, a severe fibromyalgia flare occurred, with muscle spasms, extreme pain over entire body, exhaustion, and disorientation.
Patient was given a dose of Hepatitis B, when he needed his second dose of Hepatitis A. No symptoms or danger to patient.
was very weak; Arm pain; fever; chills; This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (was very weak), MYALGIA (Arm pain), PYREXIA (fever) and CHILLS (chills) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced ASTHENIA (was very weak), MYALGIA (Arm pain), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form and IBUPROFEN at a dose of UNK dosage form. On 05-Feb-2021, ASTHENIA (was very weak), MYALGIA (Arm pain), PYREXIA (fever) and CHILLS (chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included Birth control pills.  Patient received the 1st dose on 04Jan2021 with lot No:011J20A in upper left deltoid and experienced arm pain, fever, chills, was very weak.   This case was linked to MOD-2021-194475 (Patient Link).
Arm Pain; Rash; Welts - All Over Body; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), RASH (Rash) and URTICARIA (Welts - All Over Body) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was reported.  Concurrent medical conditions included Allergy (unspecified). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), RASH (Rash) and URTICARIA (Welts - All Over Body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Rash, Urticaria and Pain in extremity, at an unspecified dose and frequency and HYDROCORTISONE ACETATE (CORTIZONE-10 [HYDROCORTISONE ACETATE]) ongoing since an unknown date for Rash, Urticaria and Pain in extremity, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm Pain), RASH (Rash) and URTICARIA (Welts - All Over Body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Delayed skin reaction that started 06/18/2021,Itching, resembled a hive reaction. Large breakout all over upper body. IV, oral, and injection steroids for treatment. Last shot was received for treatment 06/21/2021
Friday 07/23/2021  LPN contacted Pharmacy regarding incorrect dilution of Pfizer Vaccine for 2 patients (husband and wife). LPN was directed to draw up left over diluent to determine how much was injected into Pfizer Vaccine. The leftover diluent was approximately 0.6 ml. Pharmacy directed LPN to contact someone else in the Pharmacy  LPN contacted pharmacy and informed in of incorrect dilution of Pfizer Vaccine. He informed LPN that patients receiving the first dose of vaccine usually do not experience side effects. He reports that, in the event that higher than authorized dose volume were administered, patients may experience elevated side effects (fevers, body aches, chills). He informed LPN that patients should be contacted to make aware of the error and to report any side effects.  He reports that depending on the patient side effects, if any, may determine whether patient receives a second dose of vaccine. He reported that errors needed to be reported, sent email with information on how to do this to both LPN and Practice Manager. LPN contacted Practice Manager and informed her of the incorrect dilution of Pfizer Vaccine, and the information that was given by Pharmacy.  LPN spoke with the patient's provider; who contacted both patients to inform of error and potential side effects. Patients comprehended and understood. LPN and practice manager discussed a strategy which will be implemented, so this does not occur again.  The plan going forward is the following:    When diluting Pfizer vaccine, will have another person verify correct dilution and correct dosing and initial (on a     copy of the schedule)  Practice manager contacted Dr, and informed him of the incident and follow up. Practice manager will enter the incident into VAERS, per the direction of the Pharmacy Director, and will also ensure the dosage is also entered into system, as per the direction of the CDC.
pt recv vax 2OCT95 & 1hr following vax pt exp h/a, fever (temp of 103), & myalgia;pt visited the MD on 4OCT95 & was dx w/viral pneumonia;pt sx are abating slowly;
Following 1st and 2nd dose of Prevnar, client developed extreme fussiness, personality change and awoke 2-3 times every night. Symptoms started within 24 hours, post vax, and lasted approx. 2 weeks.
Pt admitted earlier this morning to several days of maroon-colored stools and acute anemia likely due to GI bleed.  Please notes for additional details. Has not noted any additional RN colored stools or other GI bleeding this morning.  Denies any abdominal pain, heartburn, chest pain, shortness of breath, dizziness or lightheadedness, or other new symptoms this morning. Noted to have positive COVID test ear.  Reports positive home COVID test 3 weeks ago and full resolution of URI symptoms that he was having at that time.  No current URI symptoms
patient called stating limited range of motion, pain, tingling. Visited primary provider. Concern of muscle, nerve, bone pain continuing. Patient reports having a feeling of pressure/resistance on injection. Concern is that discomfort is continuing one month later.
myalgia; joint pain; 103 F fever for 6 days; elevated liver enzymes; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received his second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient took the 2nd dose of the vaccine on 12Jan2021 and had myalgia, joint pain, and 103 F fever for 6 days (Jan2021). The patient also had an elevated liver enzymes (Jan2021) and a negative hepatitis serology result. The outcome of the events was unknown.  Information about batch/lot number has been requested.
Fainting syncope??Severe fatigue, dizziness, light-headedness, nausea  Stadium  was site of initial vaccine
Information has been received from a health professional concerning a female patient who on 20-AUG-2007 was vaccinated with a first dose of GARDASIL (Lot# 655165/1425F).  On 16-NOV-2007, the patient was vaccinated into the left arm with a second dose of improperly stored GARDASIL (Lot# 655165/1425F).  No adverse symptoms were noted.  At the time of this report, the patient's outcome was unknown.  No product quality complaint was involved.  Additional information is not expected.
Fever, chills, coughing, redness and swelling in left arm, hotness and hard around injection site. Got an upper respiratory infection.
15 minutes after my second dose of the COVID vaccine, I developed leg heaviness in bilateral legs and became extremely dizzy. On my way home from the hospital I received my vaccine from, I had to pull over on the side of the road as it felt like I was going to pass out. 6 hours post vaccine, about 9pm on 12/14/2021 I developed intense THROBBING, lower back pain that lasted for 14 hours straight. I had no relief and could not sleep the entire night as no position was comfortable. I developed a 102 temperature, nausea, vomiting, throbbing headache, heart rate was 125bpm, hot flashes, cold chills, diarrhea, sore throat, shortness of breath, chest pain. Today, 12/16/2021, I am still experiencing pain throughout my entire body, especially my bilateral calfs. I am weak, dizzy, fatigued, I still have chest pain all day, I am experiencing shooting pains down my right arm (the arm I received the vaccine in), I am experiencing shooting pains in my bilateral breasts, I am having deep throbbing pain in the tops of my feet. Prior to this, I was a completely healthy 28 year old that has had no issues of illness like this in the past. This vaccine has messed up my life and the vaccine is not for everyone.
Hives developed on hand after receiving vaccine. Location or hand unknown. Given 50 mg. Benadryl. No other specific information known.
Had chills. Extremely cold hands and feet. Feet also felt numb. Lasted apx 8 hrs. Sat in direct sun for several until warmed up. Feel fine today.
local reaction 9cm x 10cm-red, hot & swollen; treated advil-cool pack;
Arm a little sore; pregnant patient who was vaccinated in the third trimester; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm a little sore) and MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient who was vaccinated in the third trimester) in a 33-year-old female patient (para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-Mar-2021. On 10-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient who was vaccinated in the third trimester). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm a little sore). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Delivered NOS. She had delivered the baby. On 10-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient who was vaccinated in the third trimester) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm a little sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  No concomitant medication information was provided by the reporter.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-068523 (E2B Linked Report).; Sender's Comments:  MOD-2021-068523:2nd dose
Chills, headache, body aches. I took Tylenol and Ibuprofen
tested positive for Covid; tested positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (unknown if pregnant) received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing), notes: controlled well with medication. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 12Apr2022, outcome "unknown" and all described as "tested positive for Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (12Apr2022) positive.  Clinical Course: The patient while being quarantined had developed mild to moderate Covid symptoms. symptoms developed by patient were headache and low-grade fever.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Shot given afternoon of 10/22/04. By evening, arm started swelling and very painful to touch. Swelling continued . By next day arm 1.5 times normal size and rash appeared. Spread down arm. Saw physician 11/1/04. Put on antibiotics for 1 week and antihistamines. Fever of 100 degrees noted.
24 hrs after immunizations pt developed redness, swelling, itching and pain in right lateral thigh.  Seen in urgent care center on 8-7-11 @1247 and provider assessed as local reaction to immunizations and prescribed hydrocortisone 1% cream and Benadryl liquid
Itchiness of hands, redness of face, elevated blood pressure 30 minutes after vaccine
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2022, outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.